July 11 (Reuters) - Neptune Technologies & Bioressources Inc
NTB.TO :
* Neptune Technologies & Bioressources Inc qtrly revenues
reached $11.3 million, up 270% versus last year
* Revised revenue guidance for fiscal 2017 to over $43
million, continue to expect double-digit adjusted ebitda margin
for 2017
* Qtrly loss per share $0.03
* Consolidated cash, short term investments were $14.6
million as at may 31, 2016, with $9.6 million for co's unit
acasti
* If acasti doesn't raise funds, exists material uncertainty
that casts doubt about acasti's ability to continue as going
concern
Source text for Eikon:
Further company coverage: NTB.TO
(Bengaluru Newsroom: +1-646-223-8780)